M&T Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $550K | Buy |
4,377
+139
| +3% | +$17.5K | ﹤0.01% | 1035 |
|
|
2025
Q1 | $469K | Sell |
4,238
-2,740
| -39% | -$303K | ﹤0.01% | 1086 |
|
|
2024
Q4 | $952K | Buy |
6,978
+1,322
| +23% | +$180K | ﹤0.01% | 917 |
|
|
2024
Q3 | $651K | Sell |
5,656
-342
| -6% | -$39.4K | ﹤0.01% | 1065 |
|
|
2024
Q2 | $826K | Sell |
5,998
-189
| -3% | -$26K | ﹤0.01% | 923 |
|
|
2024
Q1 | $854K | Sell |
6,187
-597
| -9% | -$82.4K | ﹤0.01% | 927 |
|
|
2023
Q4 | $894K | Sell |
6,784
-443
| -6% | -$58.4K | ﹤0.01% | 915 |
|
|
2023
Q3 | $814K | Sell |
7,227
-2,768
| -28% | -$312K | ﹤0.01% | 914 |
|
|
2023
Q2 | $943K | Sell |
9,995
-496
| -5% | -$46.8K | ﹤0.01% | 894 |
|
|
2023
Q1 | $1.06M | Sell |
10,491
-1,184
| -10% | -$120K | ﹤0.01% | 843 |
|
|
2022
Q4 | $1.39M | Buy |
11,675
+1,529
| +15% | +$183K | 0.01% | 735 |
|
|
2022
Q3 | $1.08M | Sell |
10,146
-3,953
| -28% | -$420K | ﹤0.01% | 797 |
|
|
2022
Q2 | $294K | Buy |
14,099
+11,456
| +433% | +$239K | ﹤0.01% | 1196 |
|
|
2022
Q1 | $248K | Buy |
2,643
+92
| +4% | +$8.63K | ﹤0.01% | 1293 |
|
|
2021
Q4 | $218K | Sell |
2,551
-294
| -10% | -$25.1K | ﹤0.01% | 1409 |
|
|
2021
Q3 | $274K | Sell |
2,845
-5
| -0.2% | -$482 | ﹤0.01% | 1279 |
|
|
2021
Q2 | $278K | Buy |
2,850
+9
| +0.3% | +$878 | ﹤0.01% | 1296 |
|
|
2021
Q1 | $277K | Sell |
2,841
-163
| -5% | -$15.9K | ﹤0.01% | 1265 |
|
|
2020
Q4 | $289K | Sell |
3,004
-45
| -1% | -$4.33K | ﹤0.01% | 1360 |
|
|
2020
Q3 | $294K | Buy |
3,049
+173
| +6% | +$16.7K | ﹤0.01% | 1244 |
|
|
2020
Q2 | $351K | Sell |
2,876
-496
| -15% | -$60.5K | ﹤0.01% | 1113 |
|
|
2020
Q1 | $291K | Buy |
3,372
+59
| +2% | +$5.09K | ﹤0.01% | 1144 |
|
|
2019
Q4 | $355K | Sell |
3,313
-168
| -5% | -$18K | ﹤0.01% | 999 |
|
|
2019
Q3 | $313K | Buy |
3,481
+104
| +3% | +$9.35K | ﹤0.01% | 1172 |
|
|
2019
Q2 | $286K | Buy |
3,377
+153
| +5% | +$13K | ﹤0.01% | 1255 |
|
|
2019
Q1 | $285K | Buy |
3,224
+232
| +8% | +$20.5K | ﹤0.01% | 1233 |
|
|
2018
Q4 | $214K | Sell |
2,992
-95
| -3% | -$6.8K | ﹤0.01% | 1268 |
|
|
2018
Q3 | $380K | Buy |
3,087
+248
| +9% | +$30.5K | ﹤0.01% | 1124 |
|
|
2018
Q2 | $278K | Buy |
2,839
+13
| +0.5% | +$1.27K | ﹤0.01% | 1258 |
|
|
2018
Q1 | $235K | Buy |
2,826
+219
| +8% | +$18.2K | ﹤0.01% | 1348 |
|
|
2017
Q4 | $202K | Buy |
+2,607
| New | +$202K | ﹤0.01% | 1429 |
|
|
2016
Q4 | – | Sell |
-7,069
| Closed | -$358K | – | 1662 |
|
|
2016
Q3 | $358K | Buy |
7,069
+2,458
| +53% | +$124K | ﹤0.01% | 1193 |
|
|
2016
Q2 | $210K | Sell |
4,611
-2,042
| -31% | -$93K | ﹤0.01% | 1436 |
|
|
2016
Q1 | $262K | Buy |
+6,653
| New | +$262K | ﹤0.01% | 1342 |
|
|
2015
Q3 | – | Sell |
-6,555
| Closed | -$312K | – | 1850 |
|
|
2015
Q2 | $312K | Sell |
6,555
-219
| -3% | -$10.4K | ﹤0.01% | 1460 |
|
|
2015
Q1 | $269K | Buy |
+6,774
| New | +$269K | ﹤0.01% | 1525 |
|
|
2014
Q2 | – | Sell |
-61
| Closed | -$1K | – | 1133 |
|
|
2014
Q1 | $1K | Buy |
+61
| New | +$1K | ﹤0.01% | 1186 |
|